Clinical neurophysiology of the episodic ataxias: Insights into ion channel dysfunction in vivo

Clinical Neurophysiology

Volumn 120, Issue 10, 2009, Pages 1768-1776

  Tomlinson, Susan E ^a,b,c   Hanna, Michael G ^b   Kullmann, Dimitri M ^b   Veronica Tan, S ^c   Burke, David ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Channelopathy; Epilepsy; Episodic ataxia; Neuromyotonia; Voltage gated ion channel

Indexed keywords

CALCIUM CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; VOLTAGE GATED POTASSIUM CHANNEL;

ATAXIA; CHANNELOPATHY; CLINICAL FEATURE; DISEASE SEVERITY; ELECTRODIAGNOSIS; ELECTRONEUROLOGY; GENE MUTATION; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; ATAXIA; CALCIUM CHANNELS, L-TYPE; CHANNELOPATHIES; ELECTROPHYSIOLOGY; HUMANS; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 70350036094     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2009.07.003     Document Type: Review

References (99)

1. Adelman J.P., Bond C.T., Pessia M., and Maylie J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15 (1995) 1449-1454
2. Alonso I., Barros J., Tuna A., Coelho J., Sequeiros J., Silveira I., et al. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. Arch Neurol 60 (2003) 610-614
3. Ambrosini A., Maertens de Noordhout A., Alagona G., Dalpozzo F., and Schoenen J. Impairment of neuromuscular transmission in a subgroup of migraine patients. Neurosci Lett 276 (1999) 201-203
4. Ambrosini A., Maertens De Noordhout A., and Schoenen J. Neuromuscular transmission in migraine: a single-fiber EMG study in clinical subgroups. Neurology 56 (2001) 1038-1043
5. Ambrosini A., Sándor P.S., De Pasqua V., Pierelli F., and Schoenen J. Performances in cerebellar and neuromuscular transmission tests are correlated in migraine with aura. J Headache Pain 9 (2008) 29-32
6. Auger R.G., Daube J.R., Gomez M.R., and Lambert E.H. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol 15 (1984) 13-21
7. Baker M., Bostock H., Grafe P., and Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol 383 (1987) 45-67
8. Baloh R.W., and Winder A. Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features. Neurology 41 (1991) 429-433
9. Baloh R.W., Yue Q., Furman J.M., and Nelson S.F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41 (1997) 8-16
10. Barrett E.F., and Barrett J.N. Intracellular recording from vertebrate myelinated axons: mechanism of depolarizing afterpotential. J Physiol 323 (1982) 117-144
11. Battistini S., Stenirri S., Piatti M., Gelf C., Righetti P., Rocchi R., et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53 (1999) 38-43
12. Bergmans J. The recovery of excitability of single human motor nerve fibres after repetitive activation. Electromyography 8 (1968) 281-285
13. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., et al. A potassium channel mutation in neonatal human epilepsy. Science 279 (1998) 403-406
14. Bostock H., and Bergmans J. Post-tetanic excitability changes and ectopic discharges in a human motor axon. Brain 117 (1994) 913-928
15. Bostock H., and Baker M. Evidence for two types of potassium channel in human motor axons in vivo. Brain Res 462 (1988) 354-358
16. Bostock H., Baker M., and Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 441 (1991) 537-557
17. Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R., Smith E.A., Kramer P., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8 (1994) 136-140
18. Browne D.L., Brunt E.R.P., Griggs R.C., Nutt J.G., Gancher S.T., Smith E.A., et al. Identification of two new KCNA1 mutations in episodic ataxia/myokymia families. Hum Mol Genet 4 (1995) 1671-1672
19. Brunt E.R., and Van Weerden T.W. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 113 (1990) 1361-1382
20. Burke D., Kiernan M.C., and Bostock H. Excitability of human axons. Clin Neurophysiol 11 (2001) 1575-1585
21. Cader M., Steckley J., Dyment D., McLachlan R., and Ebers G. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 65 (2005) 156-158
22. Calandriello L., Veneziano L., Francia A., Sabbadini G., Colonnese C., Mantuano E., et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain 120 (1997) 805-812
23. Chen H., von Hehn C., Kaczmarek L.K., Ment L.R., Pober B.R., and Hisama F.M. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics 8 (2007) 131-135
24. Chioza B., Nashef L., Asherson P., and Makoff A. CACNA1A and P/Q-type calcium channels in epilepsy. Lancet 359 (2002) 258
25. vl.1. Ann Neurol 40 (1996) 684-687
26. D'Adamo M.C., Liu Z., Adelman J.P., Maylie J., and Pessia M. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J 17 (1998) 1200-1207
27. + channel function. FASEB 13 (1999) 1335-1345
28. Damji K.F., Allingham R.R., Pollock S.C., Small K., Lewis K.E., Stajich J.M., et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol 53 (1996) 338-344
29. Day N.C., Wood S.J., Ince P.G., Ince P.G., Volsen S.G., Smith W., et al. Differential localization of voltage dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction. J Neurosci 17 (1997) 6226-6235
30. Denier C., Ducros A., Vahedi K., Joutel A., Thierry P., Ritz A., et al. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 52 (1999) 1816-1821
31. Denier C., Ducros A., Durr A., Eymard B., Chassande B., and Tournier-Lasserve E. Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol 58 (2001) 292-295
32. Domitrz I., Kostera-Pruszczyk A., and Kwiecinsk I.H. A single-fibre EMG study of neuromuscular transmission in migraine patients. Cephalalgia 25 (2005) 817-821
33. Ducros A., Denier C., Joutel A., Cecillon M., Lescoat C., Vahedi K., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345 (2001) 17-24
34. Escayg A., De Waard M., Lee D.D., Bichet D., Wolf P., Mayer T., et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 66 (2000) 1531-1539
35. Eunson L.H., Rea R., Zuberi S.M., Youroukos S., Panayiotopoulos C.P., Liguori R., et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 48 (2000) 647-656
36. Fournier E., Arzel M., Sternberg D., Vicart S., Laforet P., Eymard B., et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56 (2004) 650-661
37. Fournier E., Viala K., Gervais H., Sternberg D., Arzel-Hézode M., Laforêt P., et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 60 (2006) 356-365
38. Fureman B.E., and Hess E.J. Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathy. Neurobiol Dis 20 (2005) 227-232
39. Gancher S.T., and Nutt J.G. Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord 4 (1986) 239-253
40. Graves T.D., and Hanna M.G. Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity. J Neurol 255 (2008) 1097-1099
41. Griggs R.C., Moxley R.T., and Lafrance R. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28 (1978) 1259-1264
42. Griggs R.C., and Nutt J.G. Episodic ataxias as channelopathies. Editorial. Ann Neurol 37 (1995) 285-286
43. Guida S., Trettel F., Pagnutti S., Mantuano E., Tottene A., Veneziano L., et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 68 (2001) 759-764
44. Hanna M.G. Genetic neurological channelopathies. Nat Clin Pract Neurol 5 (2006) 252-263
45. Hanson P.A., Martinez L.B., and Cassidy R. Contractures, continuous muscle discharges, and titubation. Ann Neurol 1 (1977) 120-124
46. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., and Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 (2002) 1887-1895
47. v2.1 in absence epilepsy and episodic ataxia. Brain 127 (2004) 2682-2692
48. Imbrici P., Eunson L.H., Graves T.D., Bhatia K.P., Wadia N.H., Kullmann D.M., et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65 (2005) 944-946
49. Imbrici P., D'Adamo M.C., Kullmann D.M., and Pessia M. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2. Eur J Neurosci 24 (2006) 3073-3083
50. Jen J., Yue Q., Nelson S.F., Yu H., Litt M., Nutt J., et al. A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia. Neurology 53 (1999) 34-37
51. Jen J., Wan J., Graves M., Yu H., Mock A.F., Coulin C.J., et al. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57 (2001) 1843-1848
52. Jen J., Kim G.W., and Baloh A.W. Clinical spectrum of episodic ataxia type 2. Neurology 62 (2004) 17-22
53. Jen J., Wan J., Palos T., Howard B., and Baloh R. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65 (2005) 529-534
54. Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW, the CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007;130:2484-93.
55. Jeng C.J., Chen Y.T., Chen Y.W., and Tang C.Y. Dominant-negative effects of human P/Q-type Ca2_channel mutations associated with episodic ataxia type 2. Am J Physiol Cell Physiol 290 (2006) c1209-C1220
56. Jodice C., Mantuano E., Veneziano L., Trettel F., Sabbadini G., Calandriello L., et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 6 (1997) 1973-1978
57. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358 (2001) 801-807
58. Katz B., and Miledi R. The timing of calcium action during neuromuscular transmission. J Physiol 189 (1967) 535-544
59. + channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 128 (2005) 1841-1846
60. Kinali M., Jungbluth H., Eunson L.H., Sewry C.A., Manzur A.Y., Mercuri E., et al. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscul Disord 14 (2004) 689-693
61. Klein A., Boltshauser E., Jen J., and Baloh R.W. Episodic ataxia type 1 with distal weakness - a novel manifestation of a potassium channelopathy. Neuropediatrics 35 (2004) 147-149
62. Kocsis J.D., Ruiz J.A., and Waxman S.G. Maturation of mammalian myelinated fibers: changes in action-potential characteristics following 4-aminopyridine application. J Neurophysiol 50 (1983) 449-463
63. Kors E.E., Melberg A., Vanmolkot K.R.J., Kumlien E., Haan J., Rainink R., et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63 (2004) 1136-1137
64. Lance J.W., Burke D., and Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol 5 (1979) 523-532
65. Lubbers W.J., Brunt E.R., Scheffer H., Litt M., Stulp R., Browne D.L., et al. Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide. J Neurol Neurosurg Psychiatry 59 (1995) 400-405
66. Maselli R.A., Wan J., Dunne V., Graves M., Balow R.W., Wollmann R.L., et al. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 61 (2003) 1743-1748
67. McManis P.G., Lambert E.H., and Daube J.R. The exercise test in periodic paralysis. Muscle Nerve 8 (1986) 704-710
68. Michel P., Sternberg D., Jeannet P.Y., Dunand M., Thonney F., Kress W., et al. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders. Muscle Nerve 36 (2007) 643-650
69. Miller T.M., Dias da Silva M.R., Miller H.A., Kwiecinski H., Mendell J.R., Tawil R., et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 63 (2004) 1647-1655
70. Mogyoros I., Kiernan M.C., Burke D., and Bostock H. Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain 120 (1997) 317-325
71. Neufeld M.Y., Nisipeanu P., Chistik V., and Korczyn A.D. The electroencephalogram in acetazolamide-responsive periodic ataxia. Mov Disord 11 (1996) 283-288
72. Newsom-Davis J., and Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 116 (1993) 453-469
73. 2+ channel gene. CACNL1A4. Cell 87 (1996) 543-552
74. Rajakulendran S., Schorge S., Kullmann D.M., and Hanna M.G. Episodic Ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics 4 (2007) 258-266
75. Rea R., Spauschus A., Eunson L.H., Hanna M.G., and Kullmann D.M. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1. J Physiol 538 (2002) 5-23
76. Riant F., Mourtada R., Saugier-Veber P., and Tournier-Lasserve E. Large CACNA1A deletion in a family with episodic ataxia type 2. Arch Neurol 65 (2008) 817-820
77. Schwarz J.R., Reid G., and Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch 430 (1995) 283-292
78. Shook S.J., Mamsa H., Jen J.C., Baloh R.W., and Zhou L. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea. Muscle Nerve 37 (2008) 399-402
79. Spacey S., Materek L., Szczygielski B.I., and Bird T.D. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 62 (2005) 314-316
80. Strupp M., Kalla R., Dichgans M., Freilinger T., Glasauer S., and Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62 (2004) 1623-1625
81. Strupp M., Zwergal A., and Brandt T. Episodic ataxia type 2. Neurotherapeutics 4 (2007) 267-273
82. Strupp M., Kalla R., Glasauer S., Wagner J., Hüfner K., Jahn K., et al. Aminopyridines for the treatment of cerebellar and ocular motor disorders. Prog Brain Res 171 (2008) 535-541
83. Terwindt G.M., Kors E.E., Vein A.A., Ferrari M.D., and van Dijk J.G. Single-fiber EMG in familial hemiplegic migraine. Neurology 63 (2004) 1942-1943
84. Uchitel O.D., Protti D.A., Sanchez V., Cherksey B.D., Sugimori M., and Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 89 (1992) 3330-3333
85. Vaamonde J., Artieda J., and Obeso J.A. Hereditary paroxysmal ataxia with neuromyotonia. Mov Disord 2 (1991) 180-182
86. Vacher H., Mohapatra D.P., and Trimmer J.S. Localization and targeting of voltage-dependent ion channels in Mammalian central neurons. Physiol Rev 88 (2008) 1407-1447
87. Vagg R., Mogyoros I., Kiernan M.C., and Burke D. Activity-dependent hyperpolarization of motor axons produced by natural activity. J Physiol 507 (1998) 919-925
88. Vahedi K., Joutel A., Van Bogaert P., Ducros A., Maciazeck J., Bach J.F., et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 37 (1995) 289-293
89. Van Dyke D.H., Griggs R.C., Murphy M.J., and Goldstein M.N. Hereditary myokymia and periodic ataxia. J Neurol Sci 25 (1975) 109-118
90. Veneziano L., Guida S., Mantuano E., Bernard P., Tarantino P., Boccone L., et al. Newly characterised 5' and 3' regions of CACNA1A gene harbour mutations associated with Familial Hemiplegic Migraine and Episodic Ataxia. J Neurol Sci 276 (2009) 31-37
91. Wan J., Khanna R., Sandusky M., Papazian D.M., Jen J.C., and Baloh R.W. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology 64 (2005) 2090-2097
92. v2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 277 (2002) 6960-6966
93. White J.C. Familial periodic nystagmus, vertigo, and ataxia. Arch Neurol 20 (1969) 276-280
94. Wuttke T.V., Jurkat-Rott K., Paulus W., Garncarek M., Lehmann-Horn F., and Lerche H. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology 69 (2007) 2045-2053
95. Yue Q., Jen J.C., Thwe M.M., Nelson S.F., and Baloh R.W. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. Am J Med Genet 77 (1998) 298-301
96. Zerr P., Adelman J.P., and Maylie J. Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel. FEBS Lett 431 (1998) 461-464
97. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D.W., Amos C., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the a1A-voltage dependent calcium channel. Nat Genet 15 (1997) 62-69
98. Zasorin N.L., Baloh R.W., and Myers L.B. Acetazolamide-responsive episodic ataxia syndrome. Neurology 33 (1983) 1212-1214
99. v1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122 (1999) 817-825